Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8VW55

Entry ID Method Resolution Chain Position Source
AF-Q8VW55-F1 Predicted AlphaFoldDB

No variants for Q8VW55

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q8VW55

No associated diseases with Q8VW55

2 regional properties for Q8VW55

Type Name Position InterPro Accession
domain Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain 167 - 341 IPR006131
domain Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding 21 - 161 IPR006132

Functions

Description
EC Number 2.1.3.3 Carboxy- and carbamoyltransferases
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

2 GO annotations of molecular function

Name Definition
amino acid binding Binding to an amino acid, organic acids containing one or more amino substituents.
ornithine carbamoyltransferase activity Catalysis of the reaction: carbamoyl phosphate + L-ornithine = phosphate + L-citrulline.

1 GO annotations of biological process

Name Definition
arginine catabolic process to ornithine The chemical reactions and pathways resulting in the breakdown of arginine into other compounds, including ornithine.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MEQKLGNLVK KNVVNSVFQG RSLLAEKDFT PMELEYLIDF ALHLKALKKL GISHRYLEGK
70 80 90 100 110 120
NIALLFEKTS TRTRSAFTTA SIDLGAHPEF LGSNDIQLGK KESVEDTARV LGSMFDGIEF
130 140 150 160 170 180
RGFKQSVVDD LARYSGVPVW NGLTDEWHPT QMLADFMTIK ENFGHIKNIN LSYMGDGRNN
190 200 210 220 230 240
TANSLLITGS MLGANIRIVS PKELQPSEKT TELAKKFAEK SGSRFLITDN IDEGVSKTNV
250 260 270 280 290 300
LYTDVWVSMG ESDWEDRVKL LKPYQVNMET IRKTSTPDDQ LIFMHCLPAF HDINTDYGHE
310 320 330 340 350
IFEKYGIKEM EVTDEVFRSI YARQFEEAEN RMHSIKAIMA ATLGNLFIPH V